|
1
|
Parlati ALM, Nardi E, Marzano F, Madaudo
C, Di Santo M, Cotticelli C, Agizza S, Abbellito GM, Perrone
Filardi F, Del Giudice M, et al: Advancing cardiovascular
diagnostics: The expanding role of CMR in heart failure and
cardiomyopathies. J Clin Med. 14(865)2025.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bai Y, Zheng JP, Lu F, Zhang XL, Sun CP,
Guo WH, Zou YX, Lip GYH and Shi XB: Prevalence, incidence and
mortality of hypertrophic cardiomyopathy based on a population
cohort of 21.9 million in China. Sci Rep. 12(18799)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wexler RK, Elton T, Pleister A and Feldman
D: Cardiomyopathy: An overview. Am Fam Physician. 79:778–784.
2009.PubMed/NCBI
|
|
4
|
Li T, Wang N, Yi D, Xiao Y, Li X, Shao B,
Wu Z, Bai J, Shi X, Wu C, et al: ROS-mediated ferroptosis and
pyroptosis in cardiomyocytes: An update. Life Sci.
370(123565)2025.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang Y, Zhou T, Zhao J, Zhu H, Tan X, Chen
J, Zhang Z, Shen L and Lu S: Calcium handling remodeling in dilated
cardiomyopathy: From molecular mechanisms to targeted therapies.
Channels (Austin). 19(2519545)2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hoskins AC, Jacques A, Bardswell SC,
McKenna WJ, Tsang V, dos Remedios CG, Ehler E, Adams K, Jalilzadeh
S, Avkiran M, et al: Normal passive viscoelasticity but abnormal
myofibrillar force generation in human hypertrophic cardiomyopathy.
J Mol Cell Cardiol. 49:737–745. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tanaka A, Yuasa S, Mearini G, Egashira T,
Seki T, Kodaira M, Kusumoto D, Kuroda Y, Okata S, Suzuki T, et al:
Endothelin-1 induces myofibrillar disarray and contractile vector
variability in hypertrophic cardiomyopathy-induced pluripotent stem
cell-derived cardiomyocytes. J Am Heart Assoc.
3(e001263)2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Viola H, Johnstone V, Cserne Szappanos H,
Richman T, Tsoutsman T, Filipovska A, Semsarian C and Hool L: The
L-type Ca(2+) channel facilitates abnormal metabolic activity in
the cTnI-G203S mouse model of hypertrophic cardiomyopathy. J
Physiol. 594:4051–4070. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Castillero E, Akashi H, Pendrak K,
Yerebakan H, Najjar M, Wang C, Naka Y, Mancini D, Sweeney HL, D
Armiento J, et al: Attenuation of the unfolded protein response and
endoplasmic reticulum stress after mechanical unloading in dilated
cardiomyopathy. Am J Physiol Heart Circ Physiol. 309:H459–H470.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fan G, Liu T, Chen X, Guo Y, Li X, He Y,
Hua P, Lin X, Lin D, Yan X, et al: Astaxanthin prevented acute
alcoholic cardiomyopathy by maintenance of mitophagy-mediated
mitochondrial homeostasis. J Cell Mol Med.
29(e70714)2025.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhao T, Jin K, Wang X, Su X, Wang Y, Gao
M, Luo W, Yang H and Yang Z: GPAT4 sustains endoplasmic reticulum
homeostasis in endocardial cells and safeguards heart development.
Nat Commun. 16(3345)2025.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang J, Pu X, Zhuang H, Guo Z, Wang M,
Yang H, Li C and Chang X: Astragaloside IV alleviates septic
myocardial injury through DUSP1-Prohibitin 2 mediated mitochondrial
quality control and ER-autophagy. J Adv Res. 75:561–580.
2025.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Brinkman K, Smeitink JA, Romijn JA and
Reiss P: Mitochondrial toxicity induced by nucleoside-analogue
reverse-transcriptase inhibitors is a key factor in the
pathogenesis of antiretroviral-therapy-related lipodystrophy.
Lancet. 354:1112–1115. 1999.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu ZW, Zhu HT, Chen KL, Dong X, Wei J,
Qiu C and Xue JH: Protein kinase RNA-like endoplasmic reticulum
kinase (PERK) signaling pathway plays a major role in reactive
oxygen species (ROS)-mediated endoplasmic reticulum stress-induced
apoptosis in diabetic cardiomyopathy. Cardiovasc Diabetol.
12(158)2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tarazon E, Rosello-Lleti E, Ortega A,
Gil-Cayuela C, González-Juanatey JR, Lago F, Martínez-Dolz L,
Portolés M and Rivera M: Changes in human Golgi apparatus reflect
new left ventricular dimensions and function in dilated
cardiomyopathy patients. Eur J Heart Fail. 19:280–282.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang J, Cui J, Zhao F, Yang L, Xu X, Shi
Y and Wei B: Cardioprotective effect of MLN4924 on ameliorating
autophagic flux impairment in myocardial ischemia-reperfusion
injury by Sirt1. Redox Biol. 46(102114)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kaur N, Raja R, Ruiz-Velasco A and Liu W:
Cellular protein quality control in diabetic cardiomyopathy: From
bench to bedside. Front Cardiovasc Med. 7(585309)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bresilla D, Tawfik I, Hirtl M, Gabrijelčič
S, Ostaku J, Mossegger F, Wurzer L, Lederer S, Kalinova K, Malle E,
et al: Enhancing late-life survival and mobility via mitohormesis
by reducing mitochondrial calcium levels. Aging Cell.
24(e70247)2025.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xu X, Pang Y and Fan X: Mitochondria in
oxidative stress, inflammation and aging: From mechanisms to
therapeutic advances. Signal Transduct Target Ther.
10(190)2025.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen X, Yuan T, Zheng D, Li F, Xu H, Ye M,
Liu S and Li J: Cardiomyocyte mitochondrial mono-ADP-ribosylation
dictates cardiac tolerance to sepsis by configuring bioenergetic
reserve in male mice. Nat Commun. 16(8119)2025.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang J, Meng P, Liang Y, Li X, Zhou S, Li
J, Wang X, Miao J, Shen W and Zhou L: Tubular CD44 plays a key role
in aggravating AKI through NF-ĸB p65-mediated mitochondrial
dysfunction. Cell Death Dis. 16(119)2025.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Elbatarny M, Lu YT, Hu M, Coles J, Mital
S, Ross-White A, Honjo O, Barron DJ and Gramolini AO: Systems
biology approaches investigating mitochondrial dysfunction in
cyanotic heart disease: A systematic review. EBioMedicine.
118(105839)2025.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tran DH and Wang ZV: Glucose metabolism in
cardiac hypertrophy and heart failure. J Am Heart Assoc.
8(e012673)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xu Y, Zhang X, Tang X, Zhang C, Cahoon JG,
Wang Y, Li H, Lv X, Wang Y, Wang Z, et al: Dexmedetomidine
post-treatment exacerbates metabolic disturbances in septic
cardiomyopathy via α2A-adrenoceptor. Biomed
Pharmacother. 170(115993)2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gallo G, Rubattu S and Volpe M:
Mitochondrial dysfunction in heart failure: From pathophysiological
mechanisms to therapeutic opportunities. Int J Mol Sci.
25(2667)2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wu M, Tan J, Cao Z, Cai Y, Huang Z, Chen
Z, He W, Liu X, Jiang Y, Gao Q, et al: Sirt5 improves
cardiomyocytes fatty acid metabolism and ameliorates cardiac
lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation.
Redox Biol. 73(103184)2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Guo Y, Zhang Z, Wen Z, Kang X, Wang D,
Zhang L, Cheng M, Yuan G and Ren H: Mitochondrial SIRT2-mediated
CPT2 deacetylation prevents diabetic cardiomyopathy by impeding
cardiac fatty acid oxidation. Int J Biol Sci. 21:725–744.
2025.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hu Y, Zheng Y, Liu C, You Y, Wu Y, Wang P,
Wu Y, Ba H, Lu J, Yuan Y, et al: Mitochondrial MOF regulates energy
metabolism in heart failure via ATP5B hyperacetylation. Cell Rep.
43(114839)2024.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bonora M, Wieckowski MR, Sinclair DA,
Kroemer G, Pinton P and Galluzzi L: Targeting mitochondria for
cardiovascular disorders: Therapeutic potential and obstacles. Nat
Rev Cardiol. 16:33–55. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang P, Xu S, Xu J, Xin Y, Lu Y, Zhang H,
Zhou B, Xu H, Sheu SS, Tian R and Wang W: Elevated MCU expression
by CaMKIIdeltaB limits pathological cardiac remodeling.
Circulation. 145:1067–1083. 2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Garcia-Pena LM, Abel ED and Pereira RO:
Mitochondrial dynamics, diabetes, and cardiovascular disease.
Diabetes. 73:151–161. 2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Alves-Figueiredo H, Silva-Platas C,
Estrada M, Oropeza-Almazán Y, Ramos-González M, Bernal-Ramírez J,
Vázquez-Garza E, Tellez A, Salazar-Ramírez F, Méndez-Fernández A,
et al: Mitochondrial Ca(2+) uniporter-dependent energetic
dysfunction drives hypertrophy in heart failure. JACC Basic Transl
Sci. 9:496–518. 2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Niu W, Liu X, Deng B, Hong T, Wang C, Yan
Y, Liu J, Jiang Y and Li J: Piezo1 deletion mitigates diabetic
cardiomyopathy by maintaining mitochondrial dynamics via ERK/Drp1
pathway. Cardiovasc Diabetol. 24(127)2025.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tokuyama T, Uosaki H, Sugiura A, Nishitai
G, Takeda K, Nagashima S, Shiiba I, Ito N, Amo T, Mohri S, et al:
Protective roles of MITOL against myocardial senescence and
ischemic injury partly via Drp1 regulation. iScience.
25(104582)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Thakkar C, Alikunju S, Venkatasubramanian
A, D'Mello D, Abbas H, Yang Z, Andreas I, Sayed N, Abdellatif M and
Sayed D: Constitutive expression of cardiomyocyte Klf9 precipitates
metabolic dysfunction and spontaneous cardiomyopathy. Cell Signal.
136(112146)2025.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lazarou M, Sliter DA, Kane LA, Sarraf SA,
Wang C, Burman JL, Sideris DP, Fogel AI and Youle RJ: The ubiquitin
kinase PINK1 recruits autophagy receptors to induce mitophagy.
Nature. 524:309–314. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kubli DA, Zhang X, Lee Y, Hanna RA,
Quinsay MN, Nguyen CK, Jimenez R, Petrosyan S, Murphy AN and
Gustafsson AB: Parkin protein deficiency exacerbates cardiac injury
and reduces survival following myocardial infarction. J Biol Chem.
288:915–926. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Vujic A, Koo ANM, Prag HA and Krieg T:
Mitochondrial redox and TCA cycle metabolite signaling in the
heart. Free Radic Biol Med. 166:287–296. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wang X, Li J, Zhang Y, Huang M, Yang P,
Huang T and Cheng Q: HIF1A/BNIP3 pathway affects ferroptosis in
sepsis-induced cardiomyopathy through binding to BCL-2. Redox Rep.
30(2544412)2025.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chen W, Zhao Z, Geng Z, Zhang H and Fu X:
Advances in mitochondria-nucleus crosstalk in septic
cardiomyopathy. Cell Biol Toxicol. 41(136)2025.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu H, Liu X, Zhou J and Li T:
Mitochondrial DNA Is a vital driving force in ischemia-reperfusion
injury in cardiovascular diseases. Oxid Med Cell Longev.
2022(6235747)2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lopes LR, Macken WL, Preez SD, Kotwal H,
Savvatis K, Sekhri N, Mohiddin SA, Kabiljo R and Pitceathly RDS: An
analysis of mitochondrial variation in cardiomyopathy patients from
the 100,000 genomes cohort: m.4300A>G as a cause of genetically
elusive hypertrophic cardiomyopathy. Hum Genomics.
18(136)2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Constante AD, Abreu SM and Trigo C:
Mitochondrial cardiomyopathy: A puzzle for the final diagnosis.
Cardiol Young. 34:1393–1396. 2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tragni V, Primiano G, Tummolo A, Cafferati
Beltrame L, La Piana G, Sgobba MN, Cavalluzzi MM, Paterno G,
Gorgoglione R, Volpicella M, et al: Personalized medicine in
mitochondrial health and disease: Molecular basis of therapeutic
approaches based on nutritional supplements and their analogs.
Molecules. 27(3494)2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Luppi E, De Luise M, Bini C, Pelletti G,
Tioli G, Kurelac I, Iommarini L, Pelotti S and Gasparre G: The
landscape of rare mitochondrial DNA variants in sudden cardiac
death: A potential role for ATP synthase. Heliyon.
11(e41592)2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lee JS, Ko YG, Shin KJ, Kim SK, Park JH,
Hwang KC and Pak HN: Mitochondrial DNA 4977bp deletion mutation in
peripheral blood reflects atrial remodeling in patients with
non-valvular atrial fibrillation. Yonsei Med J. 56:53–61.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhang Y, Sun X, Jin Y, Chen K, Zhang L,
Gao X, Li M, Yuan Z, Jia J, Sun A and Ge J: Mitochondrial
transplantation augments the reparative capacity of macrophages
following myocardial injury. Adv Sci (Weinh).
12(e06337)2025.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lin H, Xiong W, Fu L, Yi J and Yang J:
Damage-associated molecular patterns (DAMPs) in diseases:
Implications for therapy. Mol Biomed. 6(60)2025.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yu H, Ren K, Jin Y, Zhang L, Liu H, Huang
Z, Zhang Z, Chen X, Yang Y and Wei Z: Mitochondrial DAMPs: Key
mediators in neuroinflammation and neurodegenerative disease
pathogenesis. Neuropharmacology. 264(110217)2025.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Oka T, Hikoso S, Yamaguchi O, Taneike M,
Takeda T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, et
al: Mitochondrial DNA that escapes from autophagy causes
inflammation and heart failure. Nature. 485:251–255.
2012.PubMed/NCBI View Article : Google Scholar
|
|
51
|
He B, Yu H, Liu S, Wan H, Fu S, Liu S,
Yang J, Zhang Z, Huang H, Li Q, et al: Mitochondrial cristae
architecture protects against mtDNA release and inflammation. Cell
Rep. 41(111774)2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Mweene BC, Hatwiko H, Povia JP and Masenga
SK: The role of mitochondrial dysfunction and dynamics in
hypertensive heart disease: Mechanisms and recent advances. Biology
(Basel). 14(1212)2025.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Yan J, Cao J, Pan W and Chen L: Insights
into golgi apparatus and centrosome: Implications for ciliogenesis.
Mol Biol Rep. 52(716)2025.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ferrer MF, Rozes-Salvador V, Tomatis C,
Thomas P, Aquila S, Aguiar MCAM, Carrera Silva EA, Alvarez C and
Gómez RM: Yellow fever virus induces golgi stress and CREB3L1
nuclear translocation in human A549 cells. J Med Virol.
97(e70490)2025.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Cui C, Sun C, Yuan P, Tian S, Xie H, Xu F
and Li H: The golgi apparatus as a strategic target in cancer:
Mechanisms, diagnosis and therapeutic opportunities. J Drug Target.
33:1773–1787. 2025.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wijaya CS and Xu S: Reevaluating Golgi
fragmentation and its implications in wound repair. Cell Regen.
13(4)2024.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Gonzalez-Torrent I, Gimenez-Escamilla I,
Perez-Carrillo L, Delgado-Arija M, Portolés M, Tarazón E and
Roselló-Lletí E: Alteration in Golgi apparatus fragmentation
related genes in human dilated cardiomyopathy. Sci Rep.
15(7704)2025.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Jungk L, Franke H, Salameh A and Dhein S:
Golgi fragmentation in human patients with chronic atrial
fibrillation: A new aspect of remodeling. Thorac Cardiovasc Surg.
67:98–106. 2019.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zemet R, Hope KD, Edmondson AC, Shah R,
Patino M, Yesso AM, Berger JH, Sarafoglou K, Larson A, Lam C, et
al: Cardiomyopathy, an uncommon phenotype of congenital disorders
of glycosylation: Recommendations for baseline screening and
follow-up evaluation. Mol Genet Metab. 142(108513)2024.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Raja R, Fonseka O, Ganenthiran H,
Andrea-Ruiz-Velasco and Liu W: The multifaceted roles of ER
and Golgi in metabolic cardiomyopathy. Front Cardiovasc Med.
9(999044)2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Chatham JC and Patel RP: Protein
glycosylation in cardiovascular health and disease. Nat Rev
Cardiol. 21:525–544. 2024.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Yu P, Hu L, Xie J, Chen S, Huang L, Xu Z,
Liu X, Zhou Q, Yuan P, Yan X, et al: O-GlcNAcylation of cardiac
Nav1.5 contributes to the development of arrhythmias in diabetic
hearts. Int J Cardiol. 260:74–81. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Fang R, Jiang Q, Jia X and Jiang Z:
ARMH3-mediated recruitment of PI4KB directs Golgi-to-endosome
trafficking and activation of the antiviral effector STING.
Immunity. 56:500–515 e6. 2023.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Brandizzi F and Barlowe C: Organization of
the ER-Golgi interface for membrane traffic control. Nat Rev Mol
Cell Biol. 14:382–392. 2013.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Sikder K, Phillips E, Zhong Z, Wang N,
Saunders J, Mothy D, Kossenkov A, Schneider T, Nichtova Z, Csordas
G, et al: Perinuclear damage from nuclear envelope deterioration
elicits stress responses that contribute to LMNA cardiomyopathy.
Sci Adv. 10(eadh0798)2024.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Lu LQ, Tang MZ, Qi ZH, Huang SF, He YQ, Li
DK, Li LF and Chen LX: Regulation of the Golgi apparatus via
GOLPH3-mediated new selective autophagy. Life Sci.
253(117700)2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Chen Y, Wu Y, Tian X, Shao G, Lin Q and
Sun A: Golgiphagy: A novel selective autophagy to the fore. Cell
Biosci. 14(130)2024.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Kitta S, Kaminishi T, Higashi M, Shima T,
Nishino K, Nakamura N, Kosako H, Yoshimori T and Kuma A: YIPF3 and
YIPF4 regulate autophagic turnover of the Golgi apparatus. EMBO J.
43:2954–2978. 2024.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Huang Y and Klionsky DJ: Identification of
the YIPF3-YIPF4 heterodimer as a novel Golgiphagy receptor.
Autophagy. 20:1211–1212. 2024.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Kang J, Li CM, Kim N, Baek J and Jung YK:
Non-autophagic Golgi-LC3 lipidation facilitates TFE3 stress
response against Golgi dysfunction. EMBO J. 43:5085–5113.
2024.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Li A, Liu Y, Labapuchi Chen Z, Li S, Zhong
R, Cheng D, Chen L and He L: Development of a Golgi-targeted
fluorescent chemosensor for detecting ferrous ions overload under
Golgi stress. Spectrochim Acta A Mol Biomol Spectrosc.
294(122560)2023.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Reiling JH, Olive AJ, Sanyal S, Carette
JE, Brummelkamp TR, Ploegh HL, Starnbach MN and Sabatini DM: A
CREB3-ARF4 signalling pathway mediates the response to Golgi stress
and susceptibility to pathogens. Nat Cell Biol. 15:1473–1485.
2013.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Prola A, Nichtova Z, Pires Da Silva J,
Piquereau J, Monceaux K, Guilbert A, Gressette M, Ventura-Clapier
R, Garnier A, Zahradnik I, et al: Endoplasmic reticulum stress
induces cardiac dysfunction through architectural modifications and
alteration of mitochondrial function in cardiomyocytes. Cardiovasc
Res. 115:328–342. 2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Borbein W, Dahmlos L, Saleem U, Reinsch M,
Braren I, Schulze T, Klampe B, Cuello F, Stenzig J, Eschenhagen T
and Hansen A: Altered endoplasmic reticulum calcium loading in
human PLN-R14del cardiomyopathy. Front Cell Dev Biol.
13(1627985)2025.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Tandra V, Zhang L, Lee CM, Wu Y, Yue G, Li
H, Su H and Li J: ufmylation suppresses unfolded protein response
to prevent peripartum cardiomyopathy. JACC Basic Transl Sci.
10(101293)2025.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Chen J, Yang X, Li W, Lin Y, Lin R, Cai X,
Yan B, Xie B and Li J: Endoplasmic reticulum stress-related gene
expression causes the progression of dilated cardiomyopathy by
inducing apoptosis. Front Genet. 15(1366087)2024.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Bhattarai KR, Chaudhary M, Kim HR and Chae
HJ: Endoplasmic reticulum (ER) stress response failure in diseases.
Trends Cell Biol. 30:672–675. 2020.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Bond Newton SE, Shi X, Beratan NR, Perhacs
J, Arya JK, Bond MK, Gidalevitz T, Akay-Espinoza C, Brady DC and
Jordan-Sciutto KL: ER stress tolerance is regulated by
copper-dependent PERK kinase activity. Cell Rep.
44(116318)2025.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Wang S, Binder P, Fang Q, Wang Z, Xiao W,
Liu W and Wang X: Endoplasmic reticulum stress in the heart:
insights into mechanisms and drug targets. Br J Pharmacol.
175:1293–1304. 2018.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Qiu Y, Chen Z, He P and Wang Z:
Endoplasmic reticulum stress in cardiomyopathies: From the unfolded
protein response to therapeutic opportunities. Front Cardiovasc
Med. 12(1577186)2025.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Bertolotti A, Zhang Y, Hendershot LM,
Harding HP and Ron D: Dynamic interaction of BiP and ER stress
transducers in the unfolded-protein response. Nat Cell Biol.
2:326–332. 2000.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Han J, Back SH, Hur J, Lin YH,
Gildersleeve R, Shan J, Yuan CL, Krokowski D, Wang S, Hatzoglou M,
et al: ER-stress-induced transcriptional regulation increases
protein synthesis leading to cell death. Nat Cell Biol. 15:481–490.
2013.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Fu F and Doroudgar S: IRE1/XBP1 and
endoplasmic reticulum signaling - from basic to translational
research for cardiovascular disease. Curr Opin Physiol.
28(100552)2022.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Nakatsukasa K, Huyer G, Michaelis S and
Brodsky JL: Dissecting the ER-associated degradation of a misfolded
polytopic membrane protein. Cell. 132:101–112. 2008.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Zhu Z, Pu J, Li Y, Chen J, Ding H, Zhou A
and Zhang X: RBM25 regulates hypoxic cardiomyocyte apoptosis
through CHOP-associated endoplasmic reticulum stress. Cell Stress
Chaperones. 28:861–876. 2023.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Schiattarella GG, Altamirano F, Kim SY,
Tong D, Ferdous A, Piristine H, Dasgupta S, Wang X, French KM,
Villalobos E, et al: Xbp1s-FoxO1 axis governs lipid accumulation
and contractile performance in heart failure with preserved
ejection fraction. Nat Commun. 12(1684)2021.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Li C, Qian T, He R, Wan C, Liu Y and Yu H:
Endoplasmic reticulum-plasma membrane contact sites: Regulators,
mechanisms, and physiological functions. Front Cell Dev Biol.
9(627700)2021.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Chen C, Dai G, Fan M, Wang X, Niu K and
Gao W: Mitochondria-associated endoplasmic reticulum membranes and
myocardial ischemia: from molecular mechanisms to therapeutic
strategies. J Transl Med. 23(277)2025.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Feno S, Rizzuto R, Raffaello A and
Vecellio Reane D: The molecular complexity of the mitochondrial
calcium uniporter. Cell Calcium. 93(102322)2021.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Bai X, Zhang Z, Li X, Yang Y and Ding S:
FUNDC1: An emerging mitochondrial and MAMs protein for
mitochondrial quality control in heart diseases. Int J Mol Sci.
24(9151)2023.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Szabadkai G, Bianchi K, Varnai P, De
Stefani D, Wieckowski MR, Cavagna D, Nagy AI, Balla T and Rizzuto
R: Chaperone-mediated coupling of endoplasmic reticulum and
mitochondrial Ca2+ channels. J Cell Biol. 175:901–911.
2006.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Ong SB, Samangouei P, Kalkhoran SB and
Hausenloy DJ: The mitochondrial permeability transition pore and
its role in myocardial ischemia reperfusion injury. J Mol Cell
Cardiol. 78:23–34. 2015.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Zhihao L, Jingyu N, Lan L, Michael S, Rui
G, Xiyun B, Xiaozhi L and Guanwei F: SERCA2a: A key protein in the
Ca(2+) cycle of the heart failure. Heart Fail Rev. 25:523–535.
2020.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Zsebo K, Yaroshinsky A, Rudy JJ, Wagner K,
Greenberg B, Jessup M and Hajjar RJ: Long-term effects of
AAV1/SERCA2a gene transfer in patients with severe heart failure:
analysis of recurrent cardiovascular events and mortality. Circ
Res. 114:101–108. 2014.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Lyon AR, Babalis D, Morley-Smith AC,
Hedger M, Suarez Barrientos A, Foldes G, Couch LS, Chowdhury RA,
Tzortzis KN, Peters NS, et al: Investigation of the safety and
feasibility of AAV1/SERCA2a gene transfer in patients with chronic
heart failure supported with a left ventricular assist device - the
SERCA-LVAD TRIAL. Gene Ther. 27:579–590. 2020.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Nakagama S, Maejima Y, Fan Q,
Shiheido-Watanabe Y, Tamura N, Ihara K and Sasano T: Endoplasmic
reticulum selective autophagy alleviates anthracycline-induced
cardiotoxicity. JACC CardioOncol. 5:656–670. 2023.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Kuijpers M, Kochlamazashvili G, Stumpf A,
Puchkov D, Swaminathan A, Lucht MT, Krause E, Maritzen T, Schmitz D
and Haucke V: Neuronal autophagy regulates presynaptic
neurotransmission by controlling the axonal endoplasmic reticulum.
Neuron. 109:299–313 e9. 2021.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Stolz A, Ernst A and Dikic I: Cargo
recognition and trafficking in selective autophagy. Nat Cell Biol.
16:495–501. 2014.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Wang H, Liu L, Gong H and Li H:
Upregulation of FAM134B inhibits endoplasmic reticulum
stress-related degradation protein expression and promotes
hepatocellular carcinogenesis. J Cell Mol Med.
28(e17964)2024.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Qu Y, Gao R, Wei X, Sun X, Yang K, Shi H,
Gao Y, Hu S, Wang Y, Yang J, et al: Gasdermin D mediates
endoplasmic reticulum stress via FAM134B to regulate cardiomyocyte
autophagy and apoptosis in doxorubicin-induced cardiotoxicity. Cell
Death Dis. 13(901)2022.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Wiersma M, Meijering RAM, Qi XY, Zhang D,
Liu T, Hoogstra-Berends F, Sibon OCM, Henning RH, Nattel S and
Brundel BJJM: Endoplasmic reticulum stress is associated with
autophagy and cardiomyocyte remodeling in experimental and human
atrial fibrillation. J Am Heart Assoc. 6(e006458)2017.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Pires Da Silva J, Monceaux K, Guilbert A,
Gressette M, Piquereau J, Novotova M, Ventura-Clapier R, Garnier A
and Lemaire C: SIRT1 protects the heart from ER stress-induced
injury by promoting eEF2K/eEF2-dependent autophagy. Cells.
9(426)2020.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Karwi QG, Ho KL, Pherwani S, Ketema EB,
Sun Q and Lopaschuk GD: Concurrent diabetes and heart failure:
Interplay and novel therapeutic approaches. Cardiovasc Res.
118:686–715. 2022.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Wang T, Wei Q, Liang L, Tang X, Yao J, Lu
Y, Qu Y, Chen Z, Xing G and Cao X: OSBPL2 is required for the
binding of COPB1 to ATGL and the regulation of lipid droplet
lipolysis. iScience. 23(101252)2020.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Kaur N, Ruiz-Velasco A, Raja R, Howell G,
Miller JM, Abouleisa RRE, Ou Q, Mace K, Hille SS, Frey N, et al:
Paracrine signal emanating from stressed cardiomyocytes aggravates
inflammatory microenvironment in diabetic cardiomyopathy. iScience.
25(103973)2022.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Fonseka O, Raja R, Ross C, Gare SR, Zhang
J, Hille SS, King K, Ruiz-Velasco A, Kaur N, Chen X, et al:
XBP1s-EDEM2 prevents the onset and development of HFpEF by
ameliorating cardiac lipotoxicity. Circulation. 151:1583–1605.
2025.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Yu L, Chen Y and Tooze SA: Autophagy
pathway: Cellular and molecular mechanisms. Autophagy. 14:207–215.
2018.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Zhou R, Zhang Z, Li X, Duan Q, Miao Y,
Zhang T, Wang M, Li J, Zhang W, Wang L, et al: Autophagy in
high-fat diet and streptozotocin-induced metabolic cardiomyopathy:
Mechanisms and therapeutic implications. Int J Mol Sci.
26(1668)2025.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Gu S, Tan J, Li Q, Liu S, Ma J, Zheng Y,
Liu J, Bi W, Sha P, Li X, et al: Downregulation of LAPTM4B
contributes to the impairment of the autophagic flux via unopposed
activation of mTORC1 signaling during myocardial
ischemia/reperfusion injury. Circ Res. 127:e148–e165.
2020.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Qiao L, Hu J, Qiu X, Wang C, Peng J, Zhang
C, Zhang M, Lu H and Chen W: LAMP2A, LAMP2B and LAMP2C: Similar
structures, divergent roles. Autophagy. 19:2837–2852.
2023.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Ma X, Liu H, Foyil SR, Godar RJ,
Weinheimer CJ, Hill JA and Diwan A: Impaired autophagosome
clearance contributes to cardiomyocyte death in
ischemia/reperfusion injury. Circulation. 125:3170–3181.
2012.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Zhao YT, Cao XQ and Mu XL: Hypertrophic
cardiomyopathy secondary to deficiency in lysosome-associated
membrane protein-2: A case report. World J Cardiol. 15:609–614.
2023.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Pan B, Zhang H, Cui T and Wang X: TFEB
activation protects against cardiac proteotoxicity via increasing
autophagic flux. J Mol Cell Cardiol. 113:51–62. 2017.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Ma X, Godar RJ, Liu H and Diwan A:
Enhancing lysosome biogenesis attenuates BNIP3-induced
cardiomyocyte death. Autophagy. 8:297–309. 2012.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Patel S, Radhakrishnan D, Kumari D,
Bhansali P and Setty SRG: Restoration of β-GC trafficking improves
the lysosome function in Gaucher disease. Traffic. 24:489–503.
2023.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Beyer JN, Serebrenik YV, Toy K, Najar MA,
Feierman E, Raniszewski NR, Korb E, Shalem O and Burslem GM:
Intracellular protein editing enables incorporation of noncanonical
residues in endogenous proteins. Science.
388(eadr5499)2025.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Azevedo O, Cordeiro F, Gago MF,
Miltenberger-Miltenyi G, Ferreira C, Sousa N and Cunha D: Fabry
disease and the heart: A comprehensive review. Int J Mol Sci.
22(4434)2021.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Huang W, Zhou R, Jiang C, Wang J, Zhou Y,
Xu X, Wang T, Li A and Zhang Y: Mitochondrial dysfunction is
associated with hypertrophic cardiomyopathy in Pompe
disease-specific induced pluripotent stem cell-derived
cardiomyocytes. Cell Prolif. 57(e13573)2024.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Chen YY, Liu CX, Liu HX and Wen SY: The
emerging roles of vacuolar-type ATPase-dependent lysosomal
acidification in cardiovascular disease. Biomolecules.
15(525)2025.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Kim YC, Park HW, Sciarretta S, Mo JS,
Jewell JL, Russell RC, Wu X, Sadoshima J and Guan KL: Rag GTPases
are cardioprotective by regulating lysosomal function. Nat Commun.
5(4241)2014.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Kinouchi K, Ichihara A, Sano M, Sun-Wada
GH, Wada Y, Kurauchi-Mito A, Bokuda K, Narita T, Oshima Y, Sakoda
M, et al: The (pro)renin receptor/ATP6AP2 is essential for vacuolar
H+-ATPase assembly in murine cardiomyocytes. Circ Res. 107:30–34.
2010.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Qi J, Li Q, Xin T, Lu Q, Lin J, Zhang Y,
Luo H, Zhang F, Xing Y, Wang W, et al: MCOLN1/TRPML1 in the
lysosome: A promising target for autophagy modulation in diverse
diseases. Autophagy. 20:1712–1722. 2024.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Medina DL and Ballabio A: Lysosomal
calcium regulates autophagy. Autophagy. 11:970–971. 2015.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Scotto Rosato A, Montefusco S, Soldati C,
Di Paola S, Capuozzo A, Monfregola J, Polishchuk E, Amabile A,
Grimm C, Lombardo A, et al: TRPML1 links lysosomal calcium to
autophagosome biogenesis through the activation of the CaMKKβ/VPS34
pathway. Nat Commun. 10(5630)2019.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Xing Y, Sui Z, Liu Y, Wang MM, Wei X, Lu
Q, Wang X, Liu N, Lu C, Chen R, et al: Blunting TRPML1 channels
protects myocardial ischemia/reperfusion injury by restoring
impaired cardiomyocyte autophagy. Basic Res Cardiol.
117(20)2022.PubMed/NCBI View Article : Google Scholar
|
|
126
|
McGirr T, Onar O and Jafarnejad SM:
Dysregulated ribosome quality control in human diseases. FEBS J.
292:936–959. 2025.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Gobet C and Naef F: Ribosome profiling and
dynamic regulation of translation in mammals. Curr Opin Genet Dev.
43:120–127. 2017.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Ganapathi M, Argyriou L, Martinez-Azorin
F, Morlot S, Yigit G, Lee TM, Auber B, von Gise A, Petrey DS,
Thiele H, et al: Bi-allelic missense disease-causing variants in
RPL3L associate neonatal dilated cardiomyopathy with
muscle-specific ribosome biogenesis. Hum Genet. 139:1443–1454.
2020.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Liu WY, Wang HQ and Shao ZH: Research
progress on pathogenesis of congenital pure red cell
aplasia-review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 29:1654–1657.
2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
130
|
Desai N, Yang H, Chandrasekaran V, Kazi R,
Minczuk M and Ramakrishnan V: Elongational stalling activates
mitoribosome-associated quality control. Science. 370:1105–1110.
2020.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Balch WE, Morimoto RI, Dillin A and Kelly
JW: Adapting proteostasis for disease intervention. Science.
319:916–919. 2008.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Juszkiewicz S, Chandrasekaran V, Lin Z,
Kraatz S, Ramakrishnan V and Hegde RS: ZNF598 Is a Quality Control
Sensor of Collided Ribosomes. Mol Cell. 72:469–481 e7.
2018.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Douglas T, Zhang J, Wu Z, Abdallah K,
McReynolds M, Gilbert WV, Iwai K, Peng J, Young LH and Crews CM: An
atypical E3 ligase safeguards the ribosome during nutrient stress
bioRxiv [Preprint] 2024.10.10.617692, 2024.
|
|
134
|
Wang Y, Tu J, Wu W, Xu Y, Li Y, Pan X, Liu
B, Lu T, Han Q, Zhang H, et al: The orchestration of cell-cycle
reentry and ribosome biogenesis network is critical for cardiac
repair. Theranostics. 14:3927–3944. 2024.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Qu JH, Tarasov KV, Chakir K, Tarasova YS,
Riordon DR and Lakatta EG: Proteomic landscape and deduced
functions of the cardiac 14-3-3 protein interactome. Cells.
11(3496)2022.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Sciarretta S, Forte M, Frati G and
Sadoshima J: The complex network of mTOR signalling in the heart.
Cardiovasc Res. 118:424–439. 2022.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Yano T, Ferlito M, Aponte A, Kuno A, Miura
T, Murphy E and Steenbergen C: Pivotal role of mTORC2 and
involvement of ribosomal protein S6 in cardioprotective signaling.
Circ Res. 114:1268–1280. 2014.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Ye T, Yan Z, Chen C, Wang D, Wang A, Li T,
Yang B, Ding X and Shen C: Lactoferrin attenuates cardiac fibrosis
and cardiac remodeling after myocardial infarction via inhibiting
mTORC1/S6K signaling pathway. Theranostics. 13:3419–3433.
2023.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Zhang G, Wang X, Li C, Li Q, An YA, Luo X,
Deng Y, Gillette TG, Scherer PE and Wang ZV: Integrated stress
response couples mitochondrial protein translation with oxidative
stress control. Circulation. 144:1500–1515. 2021.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Wang Z, Wu J, Lv Z, Liang P, Li Q, Li Y
and Guo Y: LMNA-related cardiomyopathy: From molecular pathology to
cardiac gene therapy. J Adv Res. 77:443–464. 2025.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Chen SN, Lombardi R, Karmouch J, Tsai JY,
Czernuszewicz G, Taylor MRG, Mestroni L, Coarfa C, Gurha P and
Marian AJ: DNA damage response/TP53 pathway is activated and
contributes to the pathogenesis of dilated cardiomyopathy
associated with LMNA (Lamin A/C) mutations. Circ Res. 124:856–873.
2019.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Veltrop RJA, Kukk MM, Topouzidou K, Didden
L, Muchir A, van Steenbeek FG, Schurgers LJ and Harakalova M: From
gene to mechanics: A comprehensive insight into the mechanobiology
of LMNA mutations in cardiomyopathy. Cell Commun Signal.
22(197)2024.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Cenni V, Evangelisti C, Santi S, Sabatelli
P, Neri S, Cavallo M, Lattanzi G and Mattioli E: Desmin and plectin
recruitment to the nucleus and nuclei orientation are lost in
emery-dreifuss muscular dystrophy myoblasts subjected to mechanical
stimulation. Cells. 13(162)2024.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Bulmer L, Ljungman C, Hallin J, Dahlberg
P, Polte CL, Hedberg-Oldfors C, Oldfors A and Gummesson A: EMD
missense variant causes X-linked isolated dilated cardiomyopathy
with myocardial emerin deficiency. Eur J Hum Genet. 33:775–783.
2025.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Nielsen MS, van Opbergen CJM, van Veen TAB
and Delmar M: The intercalated disc: A unique organelle for
electromechanical synchrony in cardiomyocytes. Physiol Rev.
103:2271–2319. 2023.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Yeruva S and Waschke J: Structure and
regulation of desmosomes in intercalated discs: Lessons from
epithelia. J Anat. 242:81–90. 2023.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Zhao G, Qiu Y, Zhang HM and Yang D:
Intercalated discs: Cellular adhesion and signaling in heart health
and diseases. Heart Fail Rev. 24:115–132. 2019.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Sheikh F, Ross RS and Chen J: Cell-cell
connection to cardiac disease. Trends Cardiovasc Med. 19:182–190.
2009.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Wang L, Liu S, Zhang H, Hu S and Wei Y:
Arrhythmogenic cardiomyopathy: Identification of desmosomal gene
variations and desmosomal protein expression in variation carriers.
Exp Ther Med. 15:2255–2262. 2018.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Pruna M and Ehler E: The intercalated
disc: A mechanosensing signalling node in cardiomyopathy. Biophys
Rev. 12:931–946. 2020.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Rickelt S and Pieperhoff S: Mutations with
pathogenic potential in proteins located in or at the composite
junctions of the intercalated disk connecting mammalian
cardiomyocytes: A reference thesaurus for arrhythmogenic
cardiomyopathies and for Naxos and Carvajal diseases. Cell Tissue
Res. 348:325–333. 2012.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Mishra Y, Kumar A and Kaundal RK:
Mitochondrial Dysfunction is a Crucial Immune Checkpoint for
Neuroinflammation and Neurodegeneration: mtDAMPs in Focus. Mol
Neurobiol. 62:6715–6747. 2025.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Zhang G, Wei H, Zhao A, Yan X, Zhang X,
Gan J, Guo M, Wang J, Zhang F, Jiang Y, et al: Mitochondrial DNA
leakage: underlying mechanisms and therapeutic implications in
neurological disorders. J Neuroinflammation. 22(34)2025.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Guan X, Li H, Zhang L and Zhi H:
Mechanisms of mitochondrial damage-associated molecular patterns
associated with inflammatory response in cardiovascular diseases.
Inflamm Res. 74(18)2025.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Du Q, Ning N, Zhao X, Liu F, Zhang S, Xia
Y, Li F, Yuan S, Xie X, Zhu M, et al: Acylglycerol kinase inhibits
macrophage anti-tumor activity via limiting mtDNA release and
cGAS-STING-type I IFN response. Theranostics. 15:1304–1319.
2025.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Rabinowitz J, Vila IK, Luchsinger C,
Bertelli C, Schüssler M, Taffoni C, Cui B, Dai AZ, Rashid MM,
Cisneros WJ, et al: The ability of SAMHD1-deficient monocytes to
trigger the type I IFN response depends on cGAS and mitochondrial
DNA. J Biol Chem. 301(110430)2025.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Calixto A, Moen KE and Moreno SNJ: The
contribution of the Golgi and the endoplasmic reticulum to calcium
and pH homeostasis in Toxoplasma gondii. J Biol Chem.
301(108372)2025.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Sun W, Zhang J, Li S, Fu W, Liu Y, Liu M,
Dong J, Zhao X and Li X: TAB2 deficiency induces dilated
cardiomyopathy by promoting mitochondrial calcium overload in human
iPSC-derived cardiomyocytes. Mol Med. 31(42)2025.PubMed/NCBI View Article : Google Scholar
|
|
159
|
He P, Chang H, Qiu Y and Wang Z:
Mitochondria associated membranes in dilated cardiomyopathy:
Connecting pathogenesis and cellular dysfunction. Front Cardiovasc
Med. 12(1571998)2025.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Zhao WB and Sheng R: The correlation
between mitochondria-associated endoplasmic reticulum membranes
(MAMs) and Ca(2+) transport in the pathogenesis of diseases. Acta
Pharmacol Sin. 46:271–291. 2025.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Benyair R, Eisenberg-Lerner A and Merbl Y:
Maintaining Golgi homeostasis: A balancing act of two proteolytic
pathways. Cells. 11(780)2022.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Liu J, Huang Y, Li T, Jiang Z, Zeng L and
Hu Z: The role of the Golgi apparatus in disease (Review). Int J
Mol Med. 47(38)2021.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Raval KK, Tao R, White BE, De Lange WJ,
Koonce CH, Yu J, Kishnani PS, Thomson JA, Mosher DF, Ralphe JC and
Kamp TJ: Pompe disease results in a Golgi-based glycosylation
deficit in human induced pluripotent stem cell-derived
cardiomyocytes. J Biol Chem. 290:3121–3136. 2015.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Lu L, Zhou Q, Chen Z and Chen L: The
significant role of the Golgi apparatus in cardiovascular diseases.
J Cell Physiol. 233:2911–2919. 2018.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Sun Z and Brodsky JL: Protein quality
control in the secretory pathway. J Cell Biol. 218:3171–3187.
2019.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Gallagher CM and Walter P: Ceapins inhibit
ATF6alpha signaling by selectively preventing transport of ATF6α to
the Golgi apparatus during ER stress. Elife.
5(e11880)2016.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Wang L, Xu Y, Yun S, Yuan Q,
Satpute-Krishnan P and Ye Y: SAYSD1 senses UFMylated ribosome to
safeguard co-translational protein translocation at the endoplasmic
reticulum. Cell Rep. 42(112028)2023.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Izawa T, Park SH, Zhao L, Hartl FU and
Neupert W: Cytosolic protein vms1 links ribosome quality control to
mitochondrial and cellular homeostasis. Cell. 171:890–903 e18.
2017.PubMed/NCBI View Article : Google Scholar
|
